The tumour suppressor miR-34c targets MET in prostate cancer cells.
about
Dysregulation of the Met pathway in non-small cell lung cancer: implications for drug targeting and resistanceMet in urological cancersExpression of miR-34c induces G2/M cell cycle arrest in breast cancer cellsMicroRNA-144 inhibits the metastasis of gastric cancer by targeting MET expression.Expression profile of microRNAs in gastrointestinal stromal tumors revealed by high throughput quantitative RT-PCR microarray.Type 2 Diabetes Monocyte MicroRNA and mRNA Expression: Dyslipidemia Associates with Increased Differentiation-Related Genes but Not Inflammatory Activation.MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting METMicroRNA-34c Suppresses Breast Cancer Migration and Invasion by Targeting GIT1.Downregulation of miR-130b~301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer.Non-coding RNAs in Prostate Cancer: From Discovery to Clinical Applications.Regulation of the MET oncogene: molecular mechanisms.Identification of microRNA expression profile related to lymph node status in women with early-stage grade 1-2 endometrial cancer.miR-34c-5p functions as pronociceptive microRNA in cancer pain by targeting Cav2.3 containing calcium channels.Potent Inhibition of miR-34b on Migration and Invasion in Metastatic Prostate Cancer Cells by Regulating the TGF-β Pathway.Icariine Restores LPS-Induced Bone Loss by Downregulating miR-34c Level.MicroRNA-34a inhibits tumor invasion and metastasis in osteosarcoma partly by effecting C-IAP2 and Bcl-2.miR-196a Is Able to Restore the Aggressive Phenotype of Annexin A1 Knock-Out in Pancreatic Cancer Cells by CRISPR/Cas9 Genome EditingmiR-34a targets BCL-2 to suppress the migration and invasion of sinonasal squamous cell carcinoma
P2860
Q26799900-C89BF528-33C3-401B-AE9A-DB7F37C0848EQ26864988-E63D43CA-2E4E-4A05-BBA3-AC6AEB6105AEQ34017850-5E07F012-92F8-4357-812E-0FDA2846CEA1Q35562309-F9B89C56-3569-4D20-A24D-D339B69948E7Q35625368-268DB5E5-FA30-4074-B73F-746FA617922CQ35665925-E0FE8BCA-FD27-4050-93A1-680C43C16FCBQ36347188-7009713F-1BA5-448F-B193-5C76EA6CE9DCQ37290547-447EF5BF-C300-4891-9F32-2004C5042865Q37627909-BE3B3581-84D3-415E-8B65-038A34F0CE69Q38667234-2350D22F-91D1-47F8-AD0B-2A93E346445DQ38746401-1697A218-89D4-404A-9204-7D75877F29F1Q40928879-A49C7EC6-08CE-48D5-B371-6466BC0CB9BCQ49458188-3CBEB26D-00EC-4F33-A6A9-AC223B73D038Q49679082-68EA7C8D-1914-41DA-9F09-52B7CEB87902Q50231813-1A14FC42-BA7E-4F70-9746-67AE26AD4B54Q50574185-082F81D7-721A-42EB-9304-0A32A9A7725AQ57595606-EBD55EC4-82AB-4D16-A4C8-B84B956E1CA9Q58572436-98657460-EFB2-407C-9AC6-62C1CD77AF82
P2860
The tumour suppressor miR-34c targets MET in prostate cancer cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The tumour suppressor miR-34c targets MET in prostate cancer cells.
@en
The tumour suppressor miR-34c targets MET in prostate cancer cells.
@nl
type
label
The tumour suppressor miR-34c targets MET in prostate cancer cells.
@en
The tumour suppressor miR-34c targets MET in prostate cancer cells.
@nl
prefLabel
The tumour suppressor miR-34c targets MET in prostate cancer cells.
@en
The tumour suppressor miR-34c targets MET in prostate cancer cells.
@nl
P2093
P2860
P356
P1476
The tumour suppressor miR-34c targets MET in prostate cancer cells.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2013.449
P407
P577
2013-08-06T00:00:00Z